Reinhard Rychlik

Learn More
INTRODUCTION Chronic diseases substantially contribute to the continuous increase in health care expenditures, including type-2 diabetes mellitus as one of the most expensive chronic diseases. Arterial hypertension presents a risk factor for the development of type-2 diabetes mellitus. Numerous analyses have demonstrated that antihypertensive therapies(More)
OBJECTIVE To gather data about the medical and non-medical health service in patients suffering from post-stroke spasticity of the upper limb and evaluate treatment effectiveness and tolerability as well as costs over the treatment period of one year. METHODS Prospective, non-interventional, multicenter, parallel-group study comparing effectivenessand(More)
UNLABELLED HEALTH-ECONOMIC BACKGROUND: The conditions for area-wide utilisation of telemedicine on national and European levels have to be developed. Before the nation-wide implementation in Germany can take place, the effectiveness of the structures and services of telemedicine has to be verified under everyday conditions. The utilisation of telemedicine(More)
Unfortunately, the original version of this article [1] contained errors. There were formatting errors in the main text and in Tables 1, 2, 3, 4, 5 and 6. These tables have been included correctly below. There will also be an update to correct the errors in the main text. permits unrestricted use, distribution, and reproduction in any medium, provided you(More)
OBJECTIVE To compare the efficacy and safety of incobotulinumtoxinA with conventional antispastic therapy for poststroke arm spasticity in routine clinical practice over a 1-year period. DESIGN Prospective, non-interventional, open-label, parallel-group study. SETTING 47 centres in Germany. PARTICIPANTS Patients with poststroke arm spasticity; 108(More)
  • 1